2024 |
Precipio Inc
|
Independent Director |
- |
- |
2024 |
Q32 Bio Inc.
|
Independent Director |
- |
- |
2024 |
89bio Inc
|
Independent Director |
- |
- |
2024 |
CERo Therapeutics Holdings Inc.
|
Director |
- |
- |
2023 |
89bio Inc
|
- |
360.2 K |
264.9 % |
2023 |
Precipio Inc
|
Independent Director |
72.8 K |
-33.3 % |
2023 |
CERo Therapeutics Holdings Inc.
|
Independent Director |
- |
- |
2022 |
Bolt Biotherapeutics Inc
|
Independent Director |
165.1 K |
266.0 % |
2022 |
Precipio Inc
|
Independent Director |
109.2 K |
-36.0 % |
2022 |
89bio Inc
|
Independent Director |
98.7 K |
-72.3 % |
2022 |
Phoenix Biotech Acquisition Corp - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2021 |
89bio Inc
|
Independent Director |
355.7 K |
- |
2021 |
Precipio Inc
|
Independent Director |
170.6 K |
186.8 % |
2021 |
Bolt Biotherapeutics Inc
|
Independent Director |
45.1 K |
-50.9 % |
2020 |
Bolt Biotherapeutics Inc
|
Independent Director |
91.9 K |
- |
2020 |
Precipio Inc
|
Independent Director |
59.5 K |
25.8 % |
2019 |
Precipio Inc
|
Independent Director |
47.3 K |
10.5 % |
2018 |
Precipio Inc
|
Independent Director |
42.8 K |
- |
2007 |
eHealth Inc
|
Director |
11 K |
100.0 % |
2006 |
eHealth Inc
|
Director |
5.5 K |
- |
2005 |
eHealth Inc
|
Director |
- |
- |